Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.
paper
Cited
Public
Unavailable
- Authors
- O'Loughlin, J; Paradis, G; Kim, W; DiFranza, J; Meshefedjian, G; McMillan-Davey, E; Wong, S; Hanley, J; Tyndale, R F
- Year
- 2004
- Journal
- Tobacco control
- PMID
- 15564629
- DOI
- 10.1136/tc.2003.007070
- PMCID
- PMC1747926
OBJECTIVE: Case control studies in adults suggest that defective alleles in the gene that codes for the hepatic cytochrome P450 2A6 (CYP2A6) protect against nicotine dependence (ND) and higher levels of cigarette consumption. These two hypotheses were tested in young adolescents. DESIGN: Self reports of tobacco use and ND symptoms were collected every 3-4 months in a prospective study of 1293 grade 7 students from a convenience sample of 10 schools. SUBJECTS: 281 smokers with genetic data were analysed; those who were not already tobacco dependent and who had inhaled (n = 228) were followed 29.9 months on average, until they became dependent or were censored. MAIN OUTCOME MEASURES: The association between metabolic activity, represented by CYP2A6 genotype, and conversion to dependence was analysed using Cox's proportional hazards model. RESULTS: During follow up 67 subjects (29.4%) became dependent. Relative to CYP2A6*1/*1, having 1-2 copies of the inactive CYP2A6*2 or *4 variant was a strong risk factor for developing dependence (hazard ratio 2.8, 95% confidence 1.3 to 6.3). Subjects with 1-2 partially inactive CYP2A6*9 or *12 variants were not at increased risk. Mean past-week cigarette consumption at the end of follow up (controlling for age, sex, and number of months since first inhalation) among dependent subjects was 29.1 among normal inactivators, compared to 17.2, and 12.7 among slower (1-2 copies of *9 or *12), and slowest (1-2 copies of *2 or *4) inactivators, respectively (p = 0.09). CONCLUSION: Adolescents with 1-2 copies of CYP2A6*2 or *4 are at substantially increased risk of becoming dependent but smoke less once dependent. Genetic risk for ND may need to be considered in the conceptualisation of tobacco control programmes for adolescents.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Functional characterization of novel rare CYP2A6 variants and potential implications for clinical outcomes. | El-Boraie A et al. | — | 2022 | → |
| Genetic influences impacting nicotine use and abuse during adolescence: Insights from human and rodent studies. | Goldberg LR et al. | — | 2022 | → |
| Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations. | El-Boraie A et al. | — | 2021 | → |
| Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity. | El-Boraie A et al. | — | 2020 | → |
| Not all smokers appear to seek nicotine for the same reasons: implications for preclinical research in nicotine dependence. | Garcia-Rivas V et al. | — | 2019 | → |
| Association of Time to First Morning Cigarette and Chronic Obstructive Pulmonary Disease Measured by Spirometry in Current Smokers. | Kim G et al. | — | 2018 | → |
| CYP2A6 metabolism in the development of smoking behaviors in young adults. | Olfson E et al. | — | 2018 | → |
| Functional Neurocircuits and Neuroimaging Biomarkers of Tobacco Use Disorder. | Sutherland MT et al. | — | 2018 | → |
| Nicotine metabolite ratio predicts smoking topography: The Pennsylvania Adult Smoking Study. | Chen A et al. | — | 2018 | → |
| Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment. | Bozinoff N et al. | — | 2018 | → |
| CYP2A6 Genetic Variation Alters Striatal-Cingulate Circuits, Network Hubs, and Executive Processing in Smokers. | Li S et al. | — | 2017 | → |
| Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction. | López-Flores LA et al. | — | 2017 | → |
| Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages. | Pérez-Rubio G et al. | — | 2017 | → |
| Interaction between cytochrome P450 2A6 and Catechol-O-Methyltransferase genes and their association with smoking risk in young men. | Ou WC et al. | — | 2017 | → |
| Nicotine Metabolite Ratio (NMR) Prospectively Predicts Smoking Relapse: Longitudinal Findings From ITC Surveys in Five Countries. | Fix BV et al. | — | 2017 | → |
| CYP2A6 Effects on Subjective Reactions to Initial Smoking Attempt. | Cannon DS et al. | — | 2016 | → |
| CYP2A6 Longitudinal Effects in Young Smokers. | Cannon DS et al. | — | 2016 | → |
| Time to First Cigarette, a Proxy of Nicotine Dependence, Increases the Risk of Pulmonary Impairment, Independently of Current and Lifetime Smoking Behavior. | Selya AS et al. | — | 2016 | → |
| Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers. | Chenoweth MJ et al. | — | 2016 | → |
| What does addiction medicine expect from neuroscience? From genes and neurons to treatment responses. | Le Foll B | — | 2016 | → |
| Association of CYP2A6 gene polymorphisms with cigarette consumption: a meta-analysis. | Pan L et al. | — | 2015 | → |
| Cohort Profile: The Nicotine Dependence in Teens (NDIT) Study. | O'Loughlin J et al. | — | 2015 | → |
| Pharmacogenetics of nicotine and associated smoking behaviors. | Tanner JA et al. | — | 2015 | → |
| Promoter Methylation and BDNF and DAT1 Gene Expression Profiles in Patients with Drug Addiction. | Kordi-Tamandani DM et al. | — | 2015 | → |
| Finding genomic function for genetic associations in nicotine addiction research: the ENCODE project's role in future pharmacogenomic analysis. | Vandenbergh DJ et al. | — | 2014 | → |
| Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. | Chenoweth MJ et al. | — | 2014 | → |
| Smoking behaviour and compensation: a review of the literature with meta-analysis. | Scherer G et al. | — | 2014 | → |
| The Lebanese Cigarette Dependence (LCD) Score: a comprehensive tool for cigarette dependence assessment. | Salameh P et al. | — | 2014 | → |
| Age-related differences in the disposition of nicotine and metabolites in rat brain and plasma. | Vieira-Brock PL et al. | — | 2013 | → |
| Are addictions diseases or choices? | Leyton M | — | 2013 | → |
| Association between CYP2A6 genetic polymorphisms and lung cancer: a meta-analysis of case-control studies. | Liu T et al. | — | 2013 | → |
| CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers. | Chenoweth MJ et al. | — | 2013 | → |
| Exploring alternate processes contributing to the association between maternal smoking and the smoking behavior among young adult offspring. | Selya AS et al. | — | 2013 | → |
| Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokers. | Dempsey DA et al. | — | 2013 | → |
| Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse. | Li L et al. | — | 2013 | → |
| Nicotine metabolism and addiction among adolescent smokers. | Rubinstein ML et al. | — | 2013 | → |
| Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine dependence: evidence from a 4-decade longitudinal study. | Belsky DW et al. | — | 2013 | → |
| The Young Adults' Cigarette Dependence (YACD) score: an improved tool for cigarette dependence assessment in university students. | Salameh P et al. | — | 2013 | → |
| Nicotine intake and smoking topography in smokers with bipolar disorder. | Williams JM et al. | — | 2012 | → |
| PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6. | McDonagh EM et al. | — | 2012 | → |
| Risk factors for adolescent smoking: parental smoking and the mediating role of nicotine dependence. | Selya AS et al. | — | 2012 | → |
| The public health implications of the use and misuse of tobacco among the Aboriginals in Canada. | Orisatoki R | — | 2012 | → |
| Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6. | Bloom AJ et al. | — | 2012 | → |
| An investigation of social and pharmacological exposure to secondhand tobacco smoke as possible predictors of perceived nicotine dependence, smoking susceptibility, and smoking expectancies among never-smoking youth. | Racicot S et al. | — | 2011 | → |
| Associations of CYP2A6 genotype with smoking behaviors in southern China. | Liu T et al. | — | 2011 | → |
| Combined analysis of CHRNA5, CHRNA3 and CYP2A6 in relation to adolescent smoking behaviour. | Rodriguez S et al. | — | 2011 | → |
| Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century. | Khoury MJ et al. | — | 2011 | → |
| 'Smoking genes': a genetic association study. | Verde Z et al. | — | 2011 | → |
| The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans. | Bloom J et al. | — | 2011 | → |
| Breaking barriers in the genomics and pharmacogenetics of drug addiction. | Ho MK et al. | — | 2010 | → |
| Internet suicide guidelines: report of a life-threatening poisoning using tobacco extract. | Schneider S et al. | — | 2010 | → |
| Investigation of binding features: effects on the interaction between CYP2A6 and inhibitors. | Ai C et al. | — | 2010 | → |
| Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment. | Mroziewicz M et al. | — | 2010 | → |
| A link between adolescent nicotine metabolism and smoking topography. | Moolchan ET et al. | — | 2009 | → |
| Determinants of first puff and daily cigarette smoking in adolescents. | O'Loughlin J et al. | — | 2009 | → |
| Distinguishing risk factors for the onset of cravings, withdrawal symptoms and tolerance in novice adolescent smokers. | Wileyto P et al. | — | 2009 | → |
| Incorporating the family as a critical context in genetic studies of children: implications for understanding pathways to risky behavior and substance use. | Rende R et al. | — | 2009 | → |
| Molecular genetics of nicotine metabolism. | Mwenifumbo JC et al. | — | 2009 | → |
| Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. | Ray R et al. | — | 2009 | → |
| Tobacco addiction and pharmacogenetics of nicotine metabolism. | Swan GE et al. | — | 2009 | → |
| CYP2A6 polymorphisms and risk for tobacco-related cancers. | Rossini A et al. | — | 2008 | → |
| Does cigarette use influence adiposity or height in adolescence? | O'Loughlin J et al. | — | 2008 | → |
| Genetic influences on smoking cessation and relapse in pregnant women. | Triche EW et al. | — | 2008 | → |
| Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers. | Rubinstein ML et al. | — | 2008 | → |
| Tobacco addiction. | Hatsukami DK et al. | — | 2008 | → |
| Addressing tobacco-related health disparities. | Moolchan ET et al. | — | 2007 | → |
| Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. | David SP et al. | — | 2007 | → |
| Genetics and smoking behavior. | Schnoll RA et al. | — | 2007 | → |
| Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. | Mwenifumbo JC et al. | — | 2007 | → |
| On the development of nicotine dependence in adolescence. | Kandel DB et al. | — | 2007 | → |
| Overview of the pharmacogenomics of cigarette smoking. | Ho MK et al. | — | 2007 | → |
| The role of CYP2A6 in the emergence of nicotine dependence in adolescents. | Audrain-McGovern J et al. | — | 2007 | → |
| Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics. | Al Koudsi N et al. | — | 2006 | → |
| Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. | Malaiyandi V et al. | — | 2006 | → |
| Risk factors for tobacco dependence in adolescent smokers. | Karp I et al. | — | 2006 | → |
| The influence of genetics on nicotine dependence and the role of pharmacogenetics in treating the smoking habit. | Chatkin JM | — | 2006 | → |
| CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents. | Huang S et al. | — | 2005 | → |
| Epidemiology and etiology of adolescent smoking. | Schepis TS et al. | — | 2005 | → |
| Genetic influences on smoking: a brief review. | Al Koudsi N et al. | — | 2005 | → |
| Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. | Malaiyandi V et al. | — | 2005 | → |
| Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence. | Swan GE et al. | — | 2005 | → |